1. |
Silveira AP, Da Silva Manoel-Caetano F, Aoki S, et al. Gene mutations and polymorphisms of TP53 and FHIT in chronic esophagitis and esophageal carcinoma. Anticancer Res, 2011, 31(5):1685-1690.
|
2. |
Pollicino T, Saitta C, Raimondo G. Hepatocellular carcinoma:the point of view of the hepatitis B virus. Carcinogenesis, 2011, 32(8):1122-1132.
|
3. |
康凯夫, 张鑫, 陈小伍, 等. MMP-7和PTEN蛋白在原发性肝细胞性肝癌中的表达及其意义. 肿瘤防治研究, 2010, 37(6):652-655.
|
4. |
刘梅, 杨胜利, 杨付叶, 等. 一个新的与纤粘连蛋白相互作用促进肝癌细胞迁移的基因. 中国肿瘤临床, 2006, 33 (14):781-783.
|
5. |
Obara M, Sakuma T, Fujikawa K. The third type Ⅲ module of human fibroectin mediates cell adhesion and migration. J Biochem, 2010, 147(3):327-335.
|
6. |
Antonyak MA, Li B, Boroughs JL, et al. Cancer cell-derived microvesicles induce transformation by transferring tissue tran sglutaminase and fibronectin to recipient cues. Proc Natl Acad Sci USA, 2011, 108(12):4852-4857.
|
7. |
王丽. 抑癌基因PTEN在肝癌组织中的表达及HCV核心蛋白对PTEN作用的研. 西安:第四军医大学, 2007.
|
8. |
秦权林. PTEN基因多态性及PTEN蛋白表达与家族聚集性肝癌遗传易感性研究. 南宁:广西医科大学, 2009.
|
9. |
Liu H, Huang X, Liu X, et al. miR-21 promotes human nucleus pulposus cell proliferation through PTEN/AKT signaling. Int J Mol Sci, 2014, 15(3):4007-4018.
|
10. |
Athnassiadou P, Athanassiadesy P, Grapsa D, et al. The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma:a prospective immunocytochemical study. Int J Gynecol Cancer, 2007, 17(3):697-704.
|
11. |
Kechagioglou P, Papi RM, Provatopoulou X, et al. Tumor suppressor PTEN in breast cancer:heterozygosity, mutations and protein expression. Anticancer Res, 2014, 34(3):1387-1400.
|
12. |
Stanich PP, Pilarski R, Rock J, et al. Colonic manifestations of PTEN hamartoma tumor syndrome:case series and systematic review. World J Gastroenterol, 2014, 20(7):1833-1838.
|
13. |
Nogueira C, Kim KH, Sung H, et al. Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis. Oncogene, 2010, 29(47):6222-6232.
|
14. |
张缨, 贾绍昌, 项方, 等. miR-21在肝癌细胞中的表达及其与抑癌基因PTEN的关系. 临床肿瘤学杂志, 2014, 19(6):490-493.
|
15. |
Zhang M, Shan BE, Yuan NF, et al. Effect of topotecan on retinocytoma cell apoptosis and expression of Livin and PTEN. Chin Med J (Engl), 2013, 126(2):340-344.
|
16. |
白丽, 任锋, 郑素军, 等. 抑制PTEN对小鼠肝缺血再灌注损伤的保护作用及其机制. 中华肝脏病杂志, 2014, 22(6):451-455.
|
17. |
郝礼森, 张晓岚, 任昌镇, 等. PTEN过表达抑制体外活化肝星状细胞Akt的磷酸化. 实用医学杂志, 2014, 30(7):1069-1072.
|
18. |
张蕾, 杨芳, 张晓敏, 等. HBsAg阳性肝癌PTEN基因表达的研究. 滨州医学院学报. 2014, 37(4):241-243.
|
19. |
张鸣杰, 张国雷, 魏云海, 等. FHIT、FN和PTEN在肝癌组织中的表达及临床意义. 中华普通外科杂志, 2012, 27(6):487-490.
|
20. |
李秋阳, 陈惠丽, 李宁, 等. MMP-9和PTEN蛋白在胶质瘤中的表达特点及意义. 中国实验诊断学, 2013, 17(10):1811-1814.
|
21. |
Chen F, Yang D, Wang S, et al. Livin regulates prostate cancer cell invasion by impacting the NF-kβsignaling pathway and the expression of FN and CXCR4. IUBMB Life, 2012, 64(3):274-283.
|
22. |
Zhang Z, Pan J, Li L, et al. Survey of risk factors contributed to lymphatic metastasis in patients with oral tongue squamous cell carcinoma by immunohistochemistry. J Oral Pathol Med, 2011, 40(2):127-134.
|
23. |
黄宗明, 余英豪, 于媛媛, 等. 胃癌组织中CD44v6、VEGF、PTEN的表达与临床意义. 临床误诊误治杂志, 2012, 25(3):39-42.
|
24. |
王鹏, 郭琳, 王强. PTEN、Fas/FasL和MMP-2在胃癌组织的表达及其临床意义. 中国普外基础与临床杂志, 2009, 16(12):991-995.
|
25. |
丛玲华, 高志安, 钟国平, 等. 人肺癌组织E-cadherin和PTEN及HIF-1α蛋白表达临床意义的探讨. 中华肿瘤防治杂志, 2013, 20(3):196-199.
|
26. |
钟育波, 孙凯, 张晓槟, 等. X线辐射剂量对结直肠癌细胞microRNA-221和PTEN表达的影响. 中国普外基础与临床杂志, 2013, 20(10):1113-1116.
|